Soligenix (NASDAQ: SNGX - Get Free Report) and Zura Bio (NASDAQ: ZURA - Get Free Report) are both sm

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clini

Wedbush analyst Martin Fan maintains Zura Bio (NASDAQ:ZURA) with a Outperform and raises the pri

Guggenheim analyst Yatin Suneja maintains Zura Bio (NASDAQ:ZURA) with a Buy and raises the price

Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical‑stage biotechnology company developing no

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.21) per share which missed the analyst conse

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical‑stage biotech

Shares of Zura Bio Limited (NASDAQ: ZURA - Get Free Report) have received an average rating of "Mode

Zura Bio Limited (NASDAQ: ZURA - Get Free Report)'s share price rose 5.3% during trading on Friday.

On Wednesday, William Blair initiated coverage of Zura Bio Limited (NASDAQ:ZURA) with an Outperform

William Blair starts Zura Bio (NASDAQ: ZURA) at Outperform, citing tibulizumab's multibillion-do

Tibulizumab is the first and only bispecific antibody targeting both BAFF and IL-17 in clinical deve

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical stage biotech

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clini

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotech

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.22) per share which missed the analyst conse

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotech

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clini

https://www.sec.gov/ix?doc=/Archives/edgar/data/1855644/000110465926047784/tm2612540d1_8k.htm

U.S. stock futures fall around 250 points on Monday. ASTS shares drop 13.5% after satellite placed i

Zura Bio Limited (NASDAQ: ZURA - Get Free Report) has been assigned an average rating of "Moderate B

Zura Bio Limited (NASDAQ: ZURA - Get Free Report) has been given a consensus rating of "Moderate Buy

Oppenheimer analyst Justin Kim maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.49) per share which missed the analyst conse

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a cl

Zura Bio Limited (NASDAQ:ZURA) ("Zura"), a clinical-stage biotechnology company developing n

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a cl

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a cl

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA), a clinical-st

Zura Bio Limited (NASDAQ:ZURA), a clinical-stage biotechnology company developing novel and differen

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology co

Wedbush analyst Martin Fan initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating

Zura Bio Limited (Nasdaq: ZURA) ("Zura" or the "Company"), a clinical-stage biotechn

Zura Bio Limited (NASDAQ:ZURA) ("Zura"), a clinical-stage biotechnology company developing n

Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.21) per share which missed the analyst conse

Clear Street analyst Kaveri Pohlman initiates coverage on Zura Bio (NASDAQ:ZURA) with a Buy ratin

Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday&#39